ChemAxon Announces New CEO and Head of R&D

news · 12 years ago
Budapest, Hungary, 12 May 2008. ChemAxon, a software solutions provider for cheminformatics, today announced the appointment of Alex Drijver as CEO. The arrivalsignals the companies increased focus on business development and market position. Ferenc Csizmadia, founder and former CEO, moves to Chairman and Head of Research and Development. The new R&D position formalises the bridge between the customer base and the company's development strategy and in particular the next generation of products under launch. Alex joins ChemAxon with over 20 years international commercial experience, most recently as CEO and CFO of ThalesNano Inc, a Budapest based manufacturer of novel microfluidic based instruments for chemical synthesis, and CFO of ComGenex, Inc., a chemistry services provider now part ofAlbany Molecular. About ChemAxon ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visitwww.chemaxon.com.